These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 23488309)
21. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572 [TBL] [Abstract][Full Text] [Related]
22. Substantial decrease of urinary 8-oxo-7,8-dihydroguanine, a product of the base excision repair pathway, in DNA glycosylase defective mice. Rozalski R; Siomek A; Gackowski D; Foksinski M; Gran C; Klungland A; Olinski R Int J Biochem Cell Biol; 2005 Jun; 37(6):1331-6. PubMed ID: 15778095 [TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significance. Kato N; Watanabe J; Jobo T; Nishimura Y; Fujisawa T; Kamata Y; Kuramoto H J Cancer Res Clin Oncol; 2003 Apr; 129(4):222-6. PubMed ID: 12684894 [TBL] [Abstract][Full Text] [Related]
24. Role of DNA ploidy and ERB-B2 oncogene expression in the prognosis of endometrial carcinoma. Ferrara F; De Santis L; Mangili F; Sassi I; Luchini S; Mandelli C; Santambrogio G; Cantaboni A Pathol Res Pract; 1994 Nov; 190(11):1039-43. PubMed ID: 7746737 [TBL] [Abstract][Full Text] [Related]
25. Expression of telomerase reverse transcriptase mRNA and its quantitative analysis in human endometrial cancer. Oshita T; Nagai N; Ohama K Int J Oncol; 2000 Dec; 17(6):1225-30. PubMed ID: 11078809 [TBL] [Abstract][Full Text] [Related]
26. Intestinal differentiated mucinous adenocarcinoma of the endometrium with sporadic MSI high status: a case report. Trippel M; Imboden S; Papadia A; Mueller MD; Mertineit N; Härmä K; Nicolae A; Vassella E; Rau TT Diagn Pathol; 2017 May; 12(1):39. PubMed ID: 28494767 [TBL] [Abstract][Full Text] [Related]
27. [Evaluation of wild-type estrogen receptor beta and its isoforms: ER-beta/delta 5/6 i ER-beta/delta 6 in endometrial adenocarcinoma]. Witek A; Skałba P; Paul M; Graniczka M; Mazurek U; Chromy G; Wilczok T Ginekol Pol; 2003 Sep; 74(9):897-902. PubMed ID: 14674142 [TBL] [Abstract][Full Text] [Related]
28. Gastric-type Endocervical Adenocarcinoma Involving the Endometrium and Clinically Mimicking Endometrial Neoplasia: A Diagnostic Challenge. Busca A; Mirkovic J; Parra-Herran C Am J Surg Pathol; 2018 Jul; 42(7):983-985. PubMed ID: 29683820 [No Abstract] [Full Text] [Related]
29. Are we sure we know how to measure 8-oxo-7,8-dihydroguanine in DNA from human cells? Collins AR; Cadet J; Möller L; Poulsen HE; Viña J Arch Biochem Biophys; 2004 Mar; 423(1):57-65. PubMed ID: 14989265 [TBL] [Abstract][Full Text] [Related]
30. Urinary 5-hydroxymethyluracil and 8-oxo-7,8-dihydroguanine as potential biomarkers in patients with colorectal cancer. Rozalski R; Gackowski D; Siomek-Gorecka A; Starczak M; Modrzejewska M; Banaszkiewicz Z; Olinski R Biomarkers; 2015; 20(5):287-91. PubMed ID: 26329524 [TBL] [Abstract][Full Text] [Related]
31. Biomarkers in the endometrium. Berchuck A J Cell Biochem Suppl; 1995; 23():174-8. PubMed ID: 8747393 [TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor alpha mRNA variant lacking exon 5 is co-expressed with the wild-type in endometrial adenocarcinoma. Cobellis L; Reis FM; Driul L; Vultaggio G; Ferretti I; Villa E; Petraglia F Eur J Obstet Gynecol Reprod Biol; 2002 Apr; 102(1):92-5. PubMed ID: 12039098 [TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical detection of estrogen receptors on paraffin sections of normal, hyperplatic and carcinomatous endometrium. Papadimitriou CS; Athanasiadou S; Stylianidou A; Bai MK; Demoliatis J; Stephanou DG Oncology; 1992; 49(3):196-202. PubMed ID: 1495746 [TBL] [Abstract][Full Text] [Related]
34. DNA repair of 8-oxo-7,8-dihydroguanine lesions in Porphyromonas gingivalis. Henry LG; Sandberg L; Zhang K; Fletcher HM J Bacteriol; 2008 Dec; 190(24):7985-93. PubMed ID: 18849425 [TBL] [Abstract][Full Text] [Related]
35. The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: a quantitative study using laser-captured microdissected tissues. Wang Y; Liu VW; Xue WC; Tsang PC; Cheung AN; Ngan HY Gynecol Oncol; 2005 Jul; 98(1):104-10. PubMed ID: 15921730 [TBL] [Abstract][Full Text] [Related]
36. [A comparative morphometric and DNA content study of endometrial hyperplasia and adenocarcinoma]. Zhou XR; Du XG Zhonghua Fu Chan Ke Za Zhi; 1992 Sep; 27(5):278-80, 316. PubMed ID: 1298588 [TBL] [Abstract][Full Text] [Related]
37. [Expression of cellular FLICE inhibitory protein (cFLIP) in endometrial adenocarcinoma]. Chen HX; Liu YJ; Li H; Wang ZS Ai Zheng; 2004 Mar; 23(3):254-8. PubMed ID: 15025952 [TBL] [Abstract][Full Text] [Related]
38. Estrogen receptor mRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma. Rice LW; Jazaeri AA; Shupnik MA Gynecol Oncol; 1997 Apr; 65(1):149-57. PubMed ID: 9103405 [TBL] [Abstract][Full Text] [Related]
39. Re: Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papilloma virus (HPV) DNA detection. McCluggage WG Am J Surg Pathol; 2004 Jul; 28(7):974. PubMed ID: 15223971 [No Abstract] [Full Text] [Related]